AXTI
New shares, same old investor reaction
AXT Inc. decided to go shopping in the equity market after the bell on Monday, and the market’s response was basically: hard pass. The company said it plans to sell common stock in a public offering, with underwriters also getting a 30-day option to buy up to 15% more shares if demand shows up.
Why your stock chart is sulking
The actual size of the deal wasn’t disclosed, which leaves investors in that annoying “how bad is it?” limbo. But whenever a company sells stock, the first thing people think about is dilution — because if the pie gets bigger, your slice usually gets thinner.
AXT says the money is mainly meant to support its subsidiary Beijing Tongmei Xtal Technology Co. and help expand capacity for indium phosphide substrates for export. That’s the growth story here: raise cash now, build more later. The market, however, tends to hear “more shares” and immediately reach for the smelling salts.
A hot run, then a reality check
This one also comes after a wild run-up — shares were up more than 6,500% over the past year and about 381% year to date before the after-hours drop. So yes, the stock had a lot of enthusiasm baked in. New equity can cool that party fast.
Big picture: AXT is trading off a classic capital-raising tradeoff — more balance-sheet support and expansion potential, but also more dilution risk hanging over the stock.